Does providing atrial fibrillation patients, after pulmonary vein isolation, with a 1-lead ECG device relieve the emergency department?—A historically controlled prospective trial
Providing patients with AF following PVI with a 1-lead ECG device did not result in a statistically significant reduction in ED visits during the first year. However, it did improve the management of recurrent AF episodes by substituting unplanned cardioversions with scheduled ones. Clinical Trials Registration Number NCT06283654.
Authors
- Philip M. Croon
- Igor I. Tulevski (ORCID: https://orcid.org/0000-0002-8507-1531)
- Cornelis P. Allaart (ORCID: https://orcid.org/0000-0002-0506-9512)
- Jasper L. Selder (ORCID: https://orcid.org/0000-0002-0777-491X)
- Stéphanie van der Pas (ORCID: https://orcid.org/0000-0002-2448-5378)
- Jos W. R. Twisk (ORCID: https://orcid.org/0000-0001-9617-1020)
- Mark J. Mulder (ORCID: https://orcid.org/0000-0001-6784-1064)
- Albert C. van Rossum (ORCID: https://orcid.org/0000-0003-1714-4652)
- Willem R. van de Vijver
- Leontine E Wentrup
Institutions
- GGD Amsterdam (NL)
- Amsterdam University Medical Centers (NL)
- Vrije Universiteit Amsterdam (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- PLOS Digital Health
- Published
- 2024-12-20
- DOI
- https://doi.org/10.1371/journal.pdig.0000688
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00